Keywords
Brucellosis, Relapse; Complication; Registry; Developing countries
Abstract
Brucellosis is an endemic bacterial zoonotic disease in developing countries; that is a serious public health problem in Iran. Brucellosis is a life-threatening multi-system disease in human with different clinical manifestations, complications and relapse. The incidence of brucellosis in Hamadan province, west of Iran is high. In addition, there is few reliable and population-based studies regarding relapse and complications of brucellosis in developing countries, therefore establishment of the registry system in areas with adequate occurrence of cases is needed to better understand the predictors of brucellosis relapse and complications and management of the disease. Detecting occurrence of relapse and complications over time and by geographical area provide information for further investigations and identification of health system deficiencies in the management of patients.References
1. Pappas G. The changing Brucella ecology: novel reservoirs, new threats. International journal of antimicrobial agents. 2010;36:S8-S11.
2. Beeching NJ. Brucellosis. In: Jameson JL, Fauci AS, Kasper DL, editors. Harrison`s principles of internal medicine. 20th ed. New York: MC Graw-Hill; 2019. p. 1192-6.
3. Gul HC, Erdem H. Brucella species. In: Mandell GL, Bennett JE, Blaser MJ, editors. Principles and practice of infectious diseases. 9th ed. Philadelphia: Churchill Livingstone; 2020. p. 2753-8.
4. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis. 2006;6:91-9.
5. Mirnejad R, Jazi FM, Mostafaei S, Sedighi M. Epidemiology of brucellosis in Iran: A comprehensive systematic review and meta-analysis study. Microbial pathogenesis. 2017;109:239-47.
6. Golshani M, Buozari S. A review of Brucellosis in Iran: epidemiology, risk factors, diagnosis, control, and prevention. Iranian biomedical journal. 2017;21(6):349.
7. Nematollahi S, Ayubi E, Karami M, Khazaei S, Shojaeian M, Zamani R, et al. Epidemiological characteristics of human brucellosis in Hamadan Province during 2009–2015: results from the National Notifiable Diseases Surveillance System. International Journal of Infectious Diseases. 2017;61:56-61.
8. de González AB, Cox DR. Interpretation of interaction: A review. The Annals of Applied Statistics. 2007;1(2):371-85.
9. Alavi M, Alavi MR, Alavi L. Relapsed Human Brucellosis and related risk factors Pak J Med Sci. 2009;25(1):46-50.
10. Iranian Center for Disease Control (ICDC): Zonoosis office: National Guideline for Brucellosis. available at: http://brc.umsha.ac.ir/uploads/brucellosis_national_guide.pdf 2012.
11. Nimri LF. Diagnosis of recent and relapsed cases of human brucellosis by PCR assay. BMC infectious diseases. 2003;3(1):5.
12. Lundström M, Albrecht S, Serring I, Svensson K, Wendel E. Handbook for establishing quality registries. Karlskrona, Sweden: EyeNet Sweden. 2005.
13. Maurin M. Brucellosis at the dawn of the 21st century. Médecine et maladies infectieuses. 2005;35(1):6-16.
14. Mailles A, Garin-Bastuji B, Lavigne J, Jay M, Sotto A, Maurin M, et al. Human brucellosis in France in the 21st century: Results from national surveillance 2004–2013. Médecine et maladies infectieuses. 2016;46(8):411-8.
15. Roushan MH, Mohrez M, Gangi SS, Amiri MS, Hajiahmadi M. Epidemiological features and clinical manifestations in 469 adult patients with brucellosis in Babol, Northern Iran. Epidemiology & Infection. 2004;132(6):1109-14.
16. Hashemi SH, Keramat F, Ranjbar M, Mamani M, Farzam A, Jamal-Omidi S. Osteoarticular complications of brucellosis in Hamedan, an endemic area in the west of Iran. International journal of infectious diseases. 2007;11(6):496-500.
17. Roushan MRH, Baiani M, Asnafi N, Saedi F. Outcomes of 19 pregnant women with brucellosis in Babol, northern Iran. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2011;105(9):540-2.
18. Sharifkazemi MB, Moarref AR, Rezaian S, Rezaian GR. Brucella endocarditis of pseudoaneurysm of an aortic composite graft. Journal of cardiovascular ultrasound. 2013;21(4):183-5.
2. Beeching NJ. Brucellosis. In: Jameson JL, Fauci AS, Kasper DL, editors. Harrison`s principles of internal medicine. 20th ed. New York: MC Graw-Hill; 2019. p. 1192-6.
3. Gul HC, Erdem H. Brucella species. In: Mandell GL, Bennett JE, Blaser MJ, editors. Principles and practice of infectious diseases. 9th ed. Philadelphia: Churchill Livingstone; 2020. p. 2753-8.
4. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis. 2006;6:91-9.
5. Mirnejad R, Jazi FM, Mostafaei S, Sedighi M. Epidemiology of brucellosis in Iran: A comprehensive systematic review and meta-analysis study. Microbial pathogenesis. 2017;109:239-47.
6. Golshani M, Buozari S. A review of Brucellosis in Iran: epidemiology, risk factors, diagnosis, control, and prevention. Iranian biomedical journal. 2017;21(6):349.
7. Nematollahi S, Ayubi E, Karami M, Khazaei S, Shojaeian M, Zamani R, et al. Epidemiological characteristics of human brucellosis in Hamadan Province during 2009–2015: results from the National Notifiable Diseases Surveillance System. International Journal of Infectious Diseases. 2017;61:56-61.
8. de González AB, Cox DR. Interpretation of interaction: A review. The Annals of Applied Statistics. 2007;1(2):371-85.
9. Alavi M, Alavi MR, Alavi L. Relapsed Human Brucellosis and related risk factors Pak J Med Sci. 2009;25(1):46-50.
10. Iranian Center for Disease Control (ICDC): Zonoosis office: National Guideline for Brucellosis. available at: http://brc.umsha.ac.ir/uploads/brucellosis_national_guide.pdf 2012.
11. Nimri LF. Diagnosis of recent and relapsed cases of human brucellosis by PCR assay. BMC infectious diseases. 2003;3(1):5.
12. Lundström M, Albrecht S, Serring I, Svensson K, Wendel E. Handbook for establishing quality registries. Karlskrona, Sweden: EyeNet Sweden. 2005.
13. Maurin M. Brucellosis at the dawn of the 21st century. Médecine et maladies infectieuses. 2005;35(1):6-16.
14. Mailles A, Garin-Bastuji B, Lavigne J, Jay M, Sotto A, Maurin M, et al. Human brucellosis in France in the 21st century: Results from national surveillance 2004–2013. Médecine et maladies infectieuses. 2016;46(8):411-8.
15. Roushan MH, Mohrez M, Gangi SS, Amiri MS, Hajiahmadi M. Epidemiological features and clinical manifestations in 469 adult patients with brucellosis in Babol, Northern Iran. Epidemiology & Infection. 2004;132(6):1109-14.
16. Hashemi SH, Keramat F, Ranjbar M, Mamani M, Farzam A, Jamal-Omidi S. Osteoarticular complications of brucellosis in Hamedan, an endemic area in the west of Iran. International journal of infectious diseases. 2007;11(6):496-500.
17. Roushan MRH, Baiani M, Asnafi N, Saedi F. Outcomes of 19 pregnant women with brucellosis in Babol, northern Iran. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2011;105(9):540-2.
18. Sharifkazemi MB, Moarref AR, Rezaian S, Rezaian GR. Brucella endocarditis of pseudoaneurysm of an aortic composite graft. Journal of cardiovascular ultrasound. 2013;21(4):183-5.